Research
Hormonal
GLP-1 receptor agonists decrease weight in people with schizophrenia.
GLP-1 receptor agonists may be considered as a treatment option for weight management in patients with schizophrenia.
StrongSupportsmedium confidence
Results from completed trials suggest that GLP-1RAs decrease weight in people with schizophrenia.
Why this rating
Based on the completion of multiple clinical trials.
Source
GLP-1 receptor agonists and weight loss in schizophrenia – past, present, and future
Mike Trott et al. · Current Opinion in Psychiatry · 2024
reviewCited 16×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →